SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lupus drug combo study halted early: what researchers learned
Disease control TerminatedThis study tested two lupus medications—mycophenolate mofetil (MMF) alone or with voclosporin—in 12 adults with moderately severe lupus. The goal was to see if treatment response differs based on a person's immune system type. The trial was terminated early, so results are limite…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
Lupus flare prevention drug trial halted early
Disease control TerminatedThis study tested a drug called PRV-3279 to see if it could prevent lupus flares in people with active systemic lupus erythematosus (SLE). Participants first received steroids to calm their disease, then were given PRV-3279 or a placebo. The trial was stopped early, and only 28 p…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Lupus drug trial halted early: what we know
Disease control TerminatedThis study tested a drug called telitacicept in people with moderate-to-severe lupus, an autoimmune disease. The goal was to see if it could reduce disease activity and allow lower steroid use. The trial was stopped early, but results may still help researchers understand lupus t…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated May 12, 2026 13:39 UTC